In addition, cyclopamine was found to sensitize BC cells to with standard chemotherapy, enhancing the antitumor effects of paclitaxel [220], EGFR inhibitors (afatinib and gefitinib) and tamoxifen [221,222] in xenografts animal models. This evidence concerns the gene EGFR and breast cancer.